EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

COVID-19 infection raises respiratory type 2 inflammatory disease risk, whereas vaccination is protective

Henning Olbrich, Sophie L Preuß, Khalaf Kridin, Gema Hernandez, Diamant Thaçi, Ralf J Ludwig, Philip Curman

Journal of Allergy and Clinical Immunology · 2026

DOI: 10.1016/j.jaci.2025.07.030 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Allergy and Clinical Immunology, 2026. Verfasst von Henning Olbrich und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Allergy, and Venerology, University of Lübeck, Lübeck, Germany. Hauptthemen laut MEDLINE: COVID-19, SARS-CoV-2, COVID-19 Vaccines, Vaccination. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Region Stockholm, Karolinska Institutet, Schleswig-Holstein.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Coronavirus disease 2019 (COVID-19) infection and vaccination have unclear impacts on type 2 inflammatory diseases. Although viral infections can drive immune dysregulation, the extent to which COVID-19 infection and vaccination affect type 2 inflammatory diseases in various organ systems remains underexplored. OBJECTIVE: We sought to assess the risk of new-onset type 2 inflammatory diseases after COVID-19 infection and vaccination. METHODS: We conducted a large-scale retrospective matched cohort study using a US electronic health records database of more than 118 million patients. Three cohorts were defined: individuals with COVID-19 infection (n = 973,794), individuals with COVID-19 vaccination (n = 691,270), and unexposed controls (n = 4,388,409). Propensity score matching balanced demographic and clinical covariates. We calculated hazard ratios (HRs) for incident asthma, allergic rhinitis, chronic rhinosinusitis, atopic dermatitis, and eosinophilic esophagitis over 3-month follow-up. RESULTS: COVID-19 infection significantly increased the risks of asthma (HR 1.656, 95% CI 1.590-1.725), allergic rhinitis (HR 1.272, 95% CI 1.214-1.333), and chronic rhinosinusitis (HR 1.744, 95% CI 1.671-1.821). Risks for atopic dermatitis or eosinophilic esophagitis remained unchanged. In contrast, vaccination lowered the risks of asthma (HR 0.678, 95% CI 0.636-0.722) and chronic rhinosinusitis (HR 0.799, 95% CI 0.752-0.850). Direct comparison showed a 2- to 3-fold greater risk of respiratory type 2 inflammatory diseases with infection than with vaccination. CONCLUSIONS: COVID-19 infection is associated with a heightened risk of respiratory type 2 inflammatory diseases, whereas vaccination appears protective.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19SARS-CoV-2COVID-19 VaccinesVaccinationAsthmaHumansFemaleMaleMiddle AgedRetrospective StudiesAdultAgedUnited StatesRisk FactorsDermatitis, Atopic

Stichwörter der Autor:innen

COVID-19SARS-CoV-2allergic rhinitisasthmaatopic dermatitischronic rhinosinusitiseosinophilic esophagitistype 2 inflammatory diseasesvaccination

Substanzen

COVID-19 Vaccines

Autor:innen und Institutionen

  • Department of Dermatology, Allergy, and Venerology, University of Lübeck, Lübeck, Germany.
  • Department of Dermatology, Allergy, and Venerology, University of Lübeck, Lübeck, Germany; Lübeck Institute of Experimental Dermatology, University of Lübeck, Lübeck, Germany.
  • Lübeck Institute of Experimental Dermatology, University of Lübeck, Lübeck, Germany; Unit of Dermatology and Skin Research Laboratory, Galilee Medical Center, Nahariya, Israel; Azrieli Faculty of Medicine, Bar-Ilan Univ…
  • TriNetX, LLC, Cambridge, Mass; Biomedical Informatics Group Artificial Intelligence Department, E.T.S.I. Informáticos, Universidad Politécnica de Madrid, Madrid, Spain.
  • Institute and Comprehensive Center for Inflammation Medicine, University Hospital Schleswig-Holstein, Lübeck, Germany.
  • Department of Dermatology, Allergy, and Venerology, University of Lübeck, Lübeck, Germany; Lübeck Institute of Experimental Dermatology, University of Lübeck, Lübeck, Germany; Institute and Comprehensive Center for Infl…

Förderung

  • Region Stockholm
  • Karolinska Institutet
  • Schleswig-Holstein
  • Deutsche Forschungsgemeinschaft

Zitieren

APA

Olbrich, H., Preuß, S. L., Kridin, K., Hernandez, G., Thaçi, D., Ludwig, R. J., & Curman, P. (2026). COVID-19 infection raises respiratory type 2 inflammatory disease risk, whereas vaccination is protective. Journal of Allergy and Clinical Immunology. https://doi.org/10.1016/j.jaci.2025.07.030

Vancouver

Olbrich H, Preuß SL, Kridin K, Hernandez G, Thaçi D, Ludwig RJ, et al. COVID-19 infection raises respiratory type 2 inflammatory disease risk, whereas vaccination is protective. Journal of Allergy and Clinical Immunology. 2026. doi:10.1016/j.jaci.2025.07.030

BibTeX
@article{Olbrich2026,
  author = {Olbrich, Henning and Preuß, Sophie L and Kridin, Khalaf and Hernandez, Gema and Thaçi, Diamant and Ludwig, Ralf J and Curman, Philip},
  title = {COVID-19 infection raises respiratory type 2 inflammatory disease risk, whereas vaccination is protective},
  journal = {Journal of Allergy and Clinical Immunology},
  year = {2026},
  doi = {10.1016/j.jaci.2025.07.030}
}
Kostenlos starten →